{"id":"https://genegraph.clinicalgenome.org/r/96c1db67-8976-4517-9a45-1c63ef7505d2v1.0","type":"EvidenceStrengthAssertion","dc:description":"*TLK2* encodes a serine-threonine kinase involved in chromatin assembly, and DNA replication, transcription, and repair. Although *de novo* variants in *TLK2* had been observed in large-scale sequencing studies of individuals with neurodevelopmental disorders since 2014 (PMIDs: 25363768, 25533962), the first report highlighting *TLK2* variants as a cause of autosomal dominant complex neurodevelopmental disorder was published in 2016 (Lelieveld et al., PMID: 27479843). The disorder is characterized by a highly variable phenotype, including global developmental delay; borderline, mild or moderate intellectual disability; behavioral disorders including autism; gastrointestinal problems; and facial dysmorphism (PMID: 29861108). Other variable features include short stature, microcephaly, abnormalities of skull shape, and seizures.\n\nEight variants (2 frameshift, 1 nonsense, 3 splice, and 2 missense) that have been reported in eight probands in four publications (PMIDs: 25363768, 29861108, 33323470, 34821460) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. Variants occur primarily *de novo* but can be inherited from mildly affected parents. *TLK2* is highly constrained for both truncating and missense variants (gnomAD v4.1.0). The mechanism of pathogenicity appears to be loss of function, as most cases are heterozygous for truncating variants (PMID: 29861108). Reported missense variants cluster mainly in the C-terminal kinase domain; variants localized in this region show a reduction of kinase activity (PMID: 29955062). TLK2 activation requires dimerization through a coiled-coil domain, suggesting that inactive mutants could have a dominant negative effect (PMID: 29955062).\n\nThis gene-disease relationship is also supported by experimental evidence, including *in vitro* functional assays of variants showing impaired kinase activity and decreased autophosphorylation (PMID: 29955062), and protein interactions with CHD7 and CHD8, which are also involved in neurodevelopmental disorders (PMID: 29955062).\n\nIn summary, there is definitive evidence supporting the relationship between *TLK2* and autosomal dominant complex neurodevelopmental disorder. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on June 5, 2024 (SOP Version 11).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/96c1db67-8976-4517-9a45-1c63ef7505d2","GCISnapshot":"https://genegraph.clinicalgenome.org/r/ecd1054d-80b0-4292-a901-65de788b7820","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/ecd1054d-80b0-4292-a901-65de788b7820_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2025-10-19T19:03:19.620Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/ecd1054d-80b0-4292-a901-65de788b7820_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2024-06-05T10:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ecd1054d-80b0-4292-a901-65de788b7820_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ecd1054d-80b0-4292-a901-65de788b7820_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/02c680b8-e12d-4bc3-9454-9f312bd4e34a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/490fd230-b1e8-4780-bb06-2223ab5345db","type":"FunctionalAlteration","dc:description":"Four de novo TLK2 variants reported in individuals with intellectual disability (Lelieveld et al. 2016, PMID: 27479843), NM_006852.6:c.1412A>G (p.His471Arg), c.1487A>G (p.His496Arg), c.1819G>A (p.Asp607Asn), and c.2092C>T (p.Arg698Ter), showed impaired kinase activity. Variants were overexpressed in E. coli and kinase activity was examined using two TLK substrates, ASF1 and MBP. These mutants also showed more than 50% decrease in autophosphorylation.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29955062","rdfs:label":"TLK2 variants impair kinase activity and autophosphorylation"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ecd1054d-80b0-4292-a901-65de788b7820_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b4509a55-51eb-4f8e-ae52-9c0c24b26250","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/542fb5cf-9f6f-4c3f-83b6-85a9bda49960","type":"Finding","dc:description":"An unbiased proximity biotinylation assay coupled to mass spectrometry (BioID-MS) of TLK2 demonstrated interaction with numerous proteins, including CHD8 and CHD7; their direct interaction was validated using Western blot with co-immunoprecipitation. CHD8 has been associated with complex neurodevelopmental disorder and CHD7 with CHARGE syndrome. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33323470","rdfs:label":"Interactions with CHD7 and CHD8","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/ecd1054d-80b0-4292-a901-65de788b7820_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/59a3d3fd-d4f3-4f74-a5fe-f797c68ec136","type":"EvidenceLine","dc:description":"Variant inherited from mother with low-normal IQ, bipolar disorder, and facial dysmorphism.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/59a3d3fd-d4f3-4f74-a5fe-f797c68ec136_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29861108","allele":{"id":"https://genegraph.clinicalgenome.org/r/7a78b2fc-bd80-4a95-a593-e71449751e47","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006852.6(TLK2):c.1776_1783del (p.Gly593GlufsTer5)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695226775"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/00d1811c-e07c-43ed-94b1-1bbc5b23836f","type":"EvidenceLine","dc:description":"Per ID/ASD GCEP, score capped at 2 points","calculatedScore":2.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/00d1811c-e07c-43ed-94b1-1bbc5b23836f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"mRNA expression analysis demonstrated skipping of exon 18, producing an out-of-frame transcript undergoing nonsense mediated decay. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/00d1811c-e07c-43ed-94b1-1bbc5b23836f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29861108","allele":{"id":"https://genegraph.clinicalgenome.org/r/6416165c-d295-4c1a-8854-9674b061f707","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006852.6(TLK2):c.1720+1G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA400511352"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/281e6126-503d-4730-a9b6-288b978a8df3","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/281e6126-503d-4730-a9b6-288b978a8df3_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"In transfected AD-293 cells, this variant showed impaired kinase activity, comparable to the kinase dead mutation (p.Asp570Val). The affected codon is a TLK2 autophosphorylation site. The subcellular localization of the protein was also affected: whereas wild-type TLK2 showed diffuse nuclear localization, 75% of cells transfected with p.Ser595Leu showed perinuclear localization of TLK2. The mutant also caused numerous alterations in the proximal interactome of TLK2 (Pavinato et al., 2022, PMID: 33323470).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/281e6126-503d-4730-a9b6-288b978a8df3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25363768","allele":{"id":"https://genegraph.clinicalgenome.org/r/755f9b28-4673-44be-b61b-3f478f7d91f9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006852.6(TLK2):c.1784C>T (p.Ser595Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA400512424"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/07a68c6b-bde8-41f6-b254-bf26567934be","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/07a68c6b-bde8-41f6-b254-bf26567934be_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34821460","allele":{"id":"https://genegraph.clinicalgenome.org/r/72ee535d-dc73-4baa-9231-969de1b5ee99","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006852.6(TLK2):c.7del (p.Glu3LysfsTer21)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695226992"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/5bb0f087-1e1a-40df-9703-0cef1eccd3b0","type":"EvidenceLine","dc:description":"This variant is recurrent and has been documented in one additional proband (Reijners et al. 2018; PMID: 29861108). ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5bb0f087-1e1a-40df-9703-0cef1eccd3b0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34821460","allele":{"id":"https://genegraph.clinicalgenome.org/r/91363095-d22f-4f3b-a91e-387b1e4d5b30","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006852.6(TLK2):c.1121+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA400501744"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/47569646-b68a-43f9-9fc3-5567048542ed","type":"EvidenceLine","dc:description":"Variant inherited from mother with mild neurodevelopmental delay, speech delay, and facial dysmorphism. ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/47569646-b68a-43f9-9fc3-5567048542ed_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29861108","allele":{"id":"https://genegraph.clinicalgenome.org/r/394c64a6-b9d5-4029-a6c2-cc3ebc79cd0c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006852.6(TLK2):c.1460+2T>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA400506212"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/c00a09f5-7fa2-4242-9305-e37974af9442","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c00a09f5-7fa2-4242-9305-e37974af9442_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Reduced kinase activity but not statistically significant; 50% reduction in mRNA in lymphoblastoid cell line but increased protein via Western blot. The missense variant also disrupts proper chromatin organisation and exhibits an increased susceptibility to DNA damage, with higher sensitivity to Î³-ray irradiation.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/c00a09f5-7fa2-4242-9305-e37974af9442_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33323470","allele":{"id":"https://genegraph.clinicalgenome.org/r/a0ff93ab-b90a-4318-a904-7731dbdcae8c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006852.6(TLK2):c.1586A>G (p.Asp529Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA400510803"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/14c8638e-175e-4ae7-834a-cd7a89ebbb80","type":"EvidenceLine","dc:description":"Variant inherited from affected mother (borderline intellectual disability, dysmorphic facial features, microcephaly), also present in 2 affected siblings. ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/14c8638e-175e-4ae7-834a-cd7a89ebbb80_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33323470","allele":{"id":"https://genegraph.clinicalgenome.org/r/a9868363-6c17-4354-a15e-6263a8b3b608","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006852.6(TLK2):c.1357G>T (p.Glu453del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA400504461"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":12071,"specifiedBy":"GeneValidityCriteria11","strengthScore":13,"subject":{"id":"https://genegraph.clinicalgenome.org/r/o3i_cq4biMg","type":"GeneValidityProposition","disease":"obo:MONDO_0100038","gene":"hgnc:11842","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_ecd1054d-80b0-4292-a901-65de788b7820-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}